PROMIS Trial of MRI for Prostate Cancer Detection
Ground-breaking study shows that MRI before prostate is much more accurate than prostate biopsy at ruling out and ruling in important prostate cancer. Professor Ahmed was co-Chief Investigator in the study with Professor Emberton.
Ahmed HU, El-Shater Bosaily A, Brown LC, Gabe R, Kaplan R, Parmar MK, Collaco-Moraes Y, Ward K, Hindley RG, Freeman A, Kirkham AP, Oldroyd R, Parker C, Emberton M; PROMIS study group. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet. 2017 Feb 25;389(10071):815-822. The PROMIS Study in top journal The Lancet